-
公开(公告)号:SI2674428T1
公开(公告)日:2016-07-29
申请号:SI200731780
申请日:2007-04-09
Applicant: VERTEX PHARMA
Inventor: RUAH SARA S HADIDA , GROOTENHUIS PETER D J , VAN GOOR FREDRICK , ZHOU JINGLAN , BEAR BRIAN , MILLER MARK T , MCCARTNEY JASON , NUMA MEHDI MICHEL JAMEL , YANG XIAOQING
IPC: C07D405/00 , A61K31/00 , A61P31/00 , C07D471/00
-
52.
公开(公告)号:CA2688004C
公开(公告)日:2016-07-05
申请号:CA2688004
申请日:2008-05-23
Applicant: VERTEX PHARMA
Inventor: BINCH HAYLEY , GROOTENHUIS PETER , HADIDA RUAH SARA , ZHOU JINGLAN
IPC: C07D495/04 , A61K31/407 , A61P11/00
Abstract: The present invention relates to modulators of ATP-B inding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
-
公开(公告)号:AU2013270464B2
公开(公告)日:2016-05-26
申请号:AU2013270464
申请日:2013-12-10
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN , GROOTENHUIS PETER
IPC: C07D213/75 , A61K31/44 , A61K31/4427 , A61P43/00 , C07D405/12 , C07D405/14 , C07D413/14
Abstract: The present invention relates to modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators. -107-
-
公开(公告)号:CA2705562C
公开(公告)日:2016-05-17
申请号:CA2705562
申请日:2008-11-14
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN , GROOTENHUIS PETER D J
IPC: C07D217/22 , A61K31/472 , A61K31/4725 , A61P11/00 , C07D401/04 , C07D405/12 , C07D405/14
Abstract: Compounds of the present invention, of formula (I) and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
-
公开(公告)号:CA2699382C
公开(公告)日:2016-05-10
申请号:CA2699382
申请日:2008-09-15
Applicant: VERTEX PHARMA
Inventor: BINCH HAYLEY , GROOTENHUIS PETER D J , HADIDA RUAH SARA S , ZHOU JINGLAN , HAZLEWOOD ANNA , FANNING LEV T D
IPC: C07D471/04 , A61K31/4375 , A61P3/00
Abstract: The present invention relates to modulators of ATP-B inding Cassette ("ABC") transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator, compositions thereof, and methods therewith. The present invention also relates to methods of treating ABC transporter mediated diseases using such modulators.
-
公开(公告)号:PL2578571T3
公开(公告)日:2016-03-31
申请号:PL12181370
申请日:2008-11-14
Applicant: VERTEX PHARMA
Inventor: HADIDA RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN , GROOTENHUIS PETER D J
IPC: C07D217/22 , A61K31/472 , A61K31/4725 , A61P11/00 , C07D401/04 , C07D405/12 , C07D405/14
-
公开(公告)号:PL2007756T3
公开(公告)日:2016-01-29
申请号:PL07755298
申请日:2007-04-09
Applicant: VERTEX PHARMA
Inventor: RUAH SARA S HADIDA , GROOTENHUIS PETER D J , VAN GOOR FREDRICK , ZHOU JINGLAN , BEAR BRIAN , MILLER MARK T , MCCARTNEY JASON , NUMA MEHDI MICHEL JAMEL , YANG XIAOQING
IPC: C07D405/12 , A61K31/404 , A61P31/00 , C07D405/14
-
公开(公告)号:ES2552990T3
公开(公告)日:2015-12-03
申请号:ES12188920
申请日:2009-03-25
Applicant: VERTEX PHARMA
Inventor: HADIDA-RUAH SARA , MILLER MARK , ZHOU JINGLAN , BEAR BRIAN , GROOTENHUIS PETER
IPC: C07D213/75 , A61K31/44 , A61K31/4427 , A61P43/00 , C07D405/12 , C07D405/14 , C07D413/14
Abstract: Un compuesto de fórmula I:**Fórmula** o una sal farmacéuticamente aceptable del mismo, en el que: RN es H, alquilo, arilo, heteroarilo, aralquilo, cicloalquilo o heterocicloalquilo; A es un anillo monocíclico de 3 miembros; B está opcionalmente condensado a un anillo de 5-7 miembros seleccionado del grupo que consiste en cicloalifático, arilo, heterocíclico y heteroarilo; R1 es halo, alquilo, OH, alcoxi, tioalquilo, trifluorometoxi; o dos R1 en átomos adyacentes que, tomados conjuntamente, forman:**Fórmula** en el que J se selecciona del grupo que consiste en CH2, CF2 o C(CH3)2; W es, de manera independiente, un enlace o una cadena alquilideno (C1-C6) opcionalmente sustituida, en la que hasta dos unidades de metileno de W están reemplazadas, de manera independiente, por -O-, -S-, -SO2- o -NR'-; R' es, de manera independiente, H, alquilo, arilo, heteroarilo, aralquilo, cicloalquilo o heterocicloalquilo; Rw es, de manera independiente, H, CN, NO2, N(R)2, CF3, OCF3, OH, OR, C(O)N(R)2, C(O)R, CO2R, -O(alquiliden(C1-C6))-OR, O(alquiliden(C1-C6))-N(R)2, -O(alquiliden(C1-C6))-heterociclo o un alifático, cicloalifático, arilo, ariloxi, heterocíclico o heteroarilo, en el que, cuando está sustituido, Rw está sustituido con hasta dos R2; R2 es halo, CN, NO2, CF3, OCF3, OR, OC(O)R, OC(O)N(R)2, SR, S(O)R, SO2R, SO2N(R)2, SO3R, C(O)R, CO2R, C(O)N(R)2, N(R)2, NRC(O)R, NRCO2R, NRC(O)N(R)2, NRSO2R, B(OH)2 o NRSO2N(R)2; R es, de manera independiente, H, alquilo, cicloalquilo, heterocíclico, arilo o heteroarilo; n es 1 o 2; w es un número entero de 0 a 4 ambos inclusive; y x es un número entero de 0 a 5 ambos inclusive; siempre que cuando W sea un enlace y Rw sea cicloalifático, heterocicloalifático, arilo o heteroarilo, -W-Rw estará unido a la posición 3 o 4 del anillo piridilo.
-
公开(公告)号:PT2007756E
公开(公告)日:2015-11-02
申请号:PT07755298
申请日:2007-04-09
Applicant: VERTEX PHARMA
Inventor: GOOR FREDRICK VAN , BEAR BRIAN , ZHOU JINGLAN , YANG XIAOQING , GROOTENHUIS PETER D J , RUAH SARA S HADIDA , MILLER MARK T , MCCARTNEY JASON , NUMA MEHDI MICHEL JAMEL
IPC: C07D405/12 , A61K31/404 , A61P31/00 , C07D405/14
-
公开(公告)号:PT2615085E
公开(公告)日:2015-10-09
申请号:PT09188920
申请日:2009-03-25
Applicant: VERTEX PHARMA
Inventor: MILLER MARK , BEAR BRIAN , ZHOU JINGLAN , HADIDA-RUAH SARA , GROOTENHUIS PETER
IPC: C07D213/75 , A61K31/44 , A61K31/4427 , A61P43/00 , C07D405/12 , C07D405/14 , C07D413/14
-
-
-
-
-
-
-
-
-